News & Analysis as of

International Trade Health Business Organization

Read need-to-know updates, commentary, and analysis on International Trade issues written by leading professionals.

Managing Sanctions and Export Control Risks in the Health Care Industry

by Ropes & Gray LLP on

Over the past 15 years, pharmaceutical manufacturers, medical device companies, and other participants in the health care industry have been regular targets of U.S. Foreign Corrupt Practices Act (“FCPA”) enforcement actions...more

Sally Yates’ was Already Famous for Changing the Focus of Compliance Investigations - The Yates Memorandum

by Ruder Ware on

By now the whole world knows about Sally Yates. We are likely to see a lot more of her as a central figure in Congressional investigations. For some of us who deal with compliance investigations, Sally Yates was famous long...more

French Companies Must Show Duty of Care for Human and Environmental Rights

by Morgan Lewis on

After the Constitutional Court rendered its recent decision on the law regarding the duty of care of parent companies and ordering companies, the rule has finally entered into force—but is it much ado about nothing?...more

Investing in Cuban Health Care Biotech Industries

by McDermott Will & Emery on

The Obama Administration made significant new regulatory changes to allow certain investment opportunities in the Cuban health care and biotech industries. While many barriers remain, US firms in the health care industry...more

Three Questions with Former Senate Majority Leader Tom Daschle (D-SD), Founder and CEO of The Daschle Group, a Public Policy...

by Baker Donelson on

1. As we head into a new Administration and the new Congress, what do you see as the opportunities and challenges for the Affordable Care Act? The Affordable Care Act (ACA) is much greater than a single legislative action....more

Novartis Agrees to Settle Bribery Charges Against Chinese Subsidiaries for $25 Million

by Ropes & Gray LLP on

On March 23, 2015, Swiss-based pharmaceutical company Novartis AG (“Novartis”) reached a civil settlement with the United States Securities and Exchange Commission (“SEC”) for violating the internal controls and books and...more

CHINA REGULATORY ENFORCEMENT QUARTERLY - Q4 2015

by DLA Piper on

Legal and regulatory developments in Q4 2015 continue to reject attempts by the Chinese government to respond to the significant challenges presented by the slowing market economy and other domestic crises, while the country...more

Review of the 2015 Global IPO Market

According to Renaissance Capital’s 2015 Annual Review of the Global IPO Market, a total of 310 IPOs were completed in 2015 raising $156.5 billion in proceeds. This is a 35% decrease from 2014’s figures, yet remains higher...more

2016 Trends #3: Board Expectations for Ethics & Compliance Oversight Get More Specific, Uniform and Comprehensive

by NAVEX Global on

According to the U.S. Sentencing Guidelines for Organizations—and similar provisions found in other guidelines worldwide—an organization’s governing body is responsible to “exercise reasonable oversight with respect to the...more

Australia Biotech Week showcases sophistication and growth

by Dentons on

On October 9, Australia's biotech community completed its annual pilgrimage to Melbourne at the conclusion of Australia Biotech Invest 2015 and AusBiotech 2015. This year's conferences once again evidenced the primacy and...more

Real Guidance (Finally) On the Compliance Oversight Role of Boards

by NAVEX Global on

New guidance for boards of directors on what it means to have “reasonable oversight” for the implementation and effectiveness of corporate compliance programs could signal the beginning of a global trend towards more—and more...more

Tax Talk -- Volume 6, No. 3 -- October 2013

by Morrison & Foerster LLP on

In This Issue: A Primer on the Medical Device Excise Tax; FATCA Registration Begins; In re Downey Financial Corp. (U.S. Bankr. Court Dist. of Delaware 10/8/2013); In re NetBank (11th Cir. 9/10/2013); and In re...more

It's Your Business Newsletter -- December 2012

by McNees Wallace & Nurick LLC on

In This Issue: ..Export Controls: Increased Enforcement Demands an Effective Export Compliance Program - United States exporters are subject to an extremely complex and often overlapping system of export...more

Inside M&A - Fall 2012

by McDermott Will & Emery on

In This Issue: Bridging the Cross-Border M&A Gap “Korean Style”; Corporate Buyers Beware: FCPA Successor Liability – A Growing Threat; Investing In the Chinese Health Care Sector: A New Frontier to be Explored with Care;...more

ObamaCare’s Impact on Expatriate Investment Fund Partners

by King & Spalding on

The United States Supreme Court upheld the constitutionality of the Health Care and Education Reconciliation Act of 2010 (commonly referred to as ObamaCare) in a decision released June 28, 2012. A copy of the decision...more

“Sunshine” on Physician Payments

by Michael Volkov on

It is amusing to listen to companies complain about the burdens of anti-corruption compliance. It is hard to sympathize when you consider the burdens on other industries, particularly the health care industry. If the...more

Medical Device Compliance Solutions - May 2012

by Butler Snow LLP on

In This Issue: - Risky Business? Assessing Risks with A Risk Assessment Checklist - Haunting Prose: Ghostwriting and Transparency in Pharmaceutical and Medical Device Publications - 2012 In The Line Of Fire:...more

Insurance Industry Developments for Spring 2012

by Foley & Lardner LLP on

In This Issue: - The Reinsurance Industry Needs to Understand and Comply With the FCPA - Federal Health Care Reform and the Supreme Court...more

Wholly Foreign-Owned Medical Institutes No Longer Prohibited in China

by McDermott Will & Emery on

The People’s Republic of China recently eased its restrictions on foreign capital investment in the health care industry to promote private medical institutes and the establishment of wholly foreign-owned medical...more

Foreign Corrupt Practices Act (FCPA) Alert: The DOJ’s FCPA Crackdown on the Pharmaceutical and Medical Devices Industry

by Mintz Levin on

The Foreign Corrupt Practices Act (FCPA), first enacted in 1977, prohibits issuers, domestic concerns, and foreign persons acting within the U.S. from corruptly making payments to foreign government officials in exchange for...more

Corporate and Financial Weekly Digest - April 9, 2010

In this issue: *SEC/CORPORATE *BROKER DEALER ..FINRA Issues Guidance on Master Accounts and Sub-Accounts *PRIVATE INVESTMENT FUNDS ..Treasury Secretary Recommends That European Commission Maintain Level Regulatory...more

Patent Opposition in India: Recent Trends

by Rahul Dev on

Therefore, as may be seen, the two-stage patent opposition process has particularly affected the pharmaceutical industry, as the patent applicants are now vulnerable to multiple pre-grant oppositions filed by competitors, or...more

An Overview of the Foreign Corrupt Practices Act for Healthcare Companies

This article was contributed by ILN member firm Epstein Becker & Green. The globalization of healthcare has resulted in U.S. healthcare companies working with government agencies and government healthcare systems in...more

23 Results
|
View per page
Page: of 1
Cybersecurity

Follow International Trade Updates on:

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.